N4 Pharma Plc (N4P.L) LSE
0.48
+0(+0.00%)
Currency In GBp
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 1.79M |
| Enterprise Value | 1.16M |
| P/E Ratio | -3.4 |
| PEG Ratio | -0.08 |
| Price/Sales Ratio | 765.61 |
| Price/Book Ratio | 2.12 |
| Enterprise/Revenue | 521.13 |
| Enterprise/EBITDA | -3.07 |
Fiscal Year
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | June 30, 2025 |
Profitability
| Profit Margin | -156.04 |
| Operating Margin | -161.34 |
Management Effectiveness
| Return On Assets | -0.6 |
| Return On Equity | -0.91 |
Income Statement
| Revenue | 7,282 |
| Revenue/Share | 0 |
| Gross Profit | 7,282 |
| EBITDA | -1.22M |
| Net Income | -1.06M |
| Diluted EPS | -0 |
Balance Sheet
| Total Cash | 1.73M |
| Total Cash/Share | 0 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 23.55 |
| Book Value Per Share | 0 |
Price History
| 52-Week Change | 26.67 |
| 52-Week High | 1 |
| 52-Week Low | 0.35 |
| Moving Average 50 Days | 0.49 |
| Moving Average 200 Days | 0.51 |
Statistics
| Average Volume | 566,465 |
| Shares Outstanding | 832.28M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 1:4 |
| Last Split Date | May 03, 2017 |
